IMAX Corporation (IMAX) SEC Filings & Earnings Calls
EquiReason read 14 IMAX Corporation SEC filings in the last 12 months. Latest: 8-K on 2026-08-21 — Reported a director or officer change (departure, election, appointment or pay arrangement).
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 2.9B
- P/E TTM
- 74.1
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
23 Jul 20268-K · 2.02Total Revenue $103M (+12% y/y); Gross Margin 61.2; Net Income $16M (+30% y/y)earningsopen
Figures in the filing · each found in the filing text
| Total Revenue · total · Q2-2026 | $103M | +12% y/y |
| Gross Margin · total · Q2-2026 | 61.2% | |
| Net Income · total · Q2-2026 | $16M | +30% y/y |
| Net Income per Share - Diluted · total · Q2-2026 | $0.27 | +35% y/y |
| Total Adjusted EBITDA · total · Q2-2026 | $48M | +23% y/y |
| Adjusted Earnings Per Share - Diluted · total · Q2-2026 | $0.43 | +65% y/y |
| Content Solutions Revenue · Content Solutions · Q2-2026 | $35M | +2% y/y |
| Technology Products and Services Revenue · Technology Products and Services · Q2-2026 | $65M | +17% y/y |
| Q2 Installations · Technology Products and Services · Q2-2026 | 38 |
Risks flagged
Content Solutions gross margin declined from 66% to 63% YoY, indicating potential mix shift or cost pressure.
“Content Solutions: Gross Margin 63% vs 66% (-300bps)”
Dependence on blockbuster content slate; any delays or underperformance could impact future results.
“The Odyssey kicks off a stellar second half 2026 slate... Dune: Part Three” · word for word
23 Jul 202610-QIMAX reported strong Q2 2026 results with revenue up 12.2% YoY and significant margin expansion in Technology Products and Services.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $103M | +12% y/y |
| Technology Products and Services Revenue · Technology Products and Services · Q2-2026 | $65M | +17% y/y |
| Content Solutions Revenue · Content Solutions · Q2-2026 | $35M | +2% y/y |
| Global Box Office · H1-2026 | $545M |
Risks flagged
China Revenue Concentration
“Greater China 13,881 17,677 34,449 57,802” · word for word
Currency Fluctuation Risk
“The Company is exposed to market risk from changes in foreign currency rates.” · word for word
30 Apr 20268-K · 2.02IMAX reports Q1 2026 results: revenue $81.4M (-6% YoY), net income $4.2M (+83%), reaffirms FY2026 guidance of $1.4B global box office. CEO on medical leave transitioning back.earningsopen
Figures in the filing · each found in the filing text
| Total Revenue · Q1-2026 | $81M | -6% y/y |
| Net Income Attributable to Common Shareholders · Q1-2026 | $4M | +83% y/y |
| Gross Margin (%) · Q1-2026 | 56.3% | |
| Total Adjusted EBITDA · Q1-2026 | $31M | -18% y/y |
| Global Box Office · Q1-2026 | $260M | |
| Systems Signed (YTD) · Q1-2026 | 42 | |
| Technology Products and Services Revenue · Technology Products and Services · Q1-2026 | $48M | -5% y/y |
| Diluted EPS · Q1-2026 | $0.07 | +75% y/y |
| Adjusted Diluted EPS · Q1-2026 | $0.17 | +31% y/y |
Guidance
FY2026 global box office ~$1.4B
Reaffirmed FY2026 guidance of $1.4B global box office; strong slate ahead; margin pressure from China mix but network expansion positive.
Risks flagged
China box office weakness continues; Greater China revenue declined significantly.
“Greater China’s box office was impacted by the combination of the record Chinese New Year... Content Solutions revenues decreased 8% to $31 million and gross margin decreased 22% to $18 million year-over-year, respectively, driven by lower box office in China.”
CEO on medical leave introduces key-person risk, though gradual return underway.
“IMAX CEO Rich Gelfond gradually resuming leadership duties and engaged in key strategic decision-making as he transitions from temporary medical leave.” · word for word
30 Apr 202610-QTotal Revenue $81M (-6% y/y); Gross Margin $46M (-14% y/y); Global Box Office $260Mopen
Figures in the filing · each found in the filing text
| Total Revenue · Q1-2026 | $81M | -6% y/y |
| Gross Margin · Q1-2026 | $46M | -14% y/y |
| Global Box Office · Q1-2026 | $260M | |
| IMAX System Count · 2026-03-31 | 1,865 | +3% y/y |
| Content Solutions Revenue · Content Solutions · Q1-2026 | $31M | -8% y/y |
| Technology Products and Services Revenue · Technology Products and Services · Q1-2026 | $48M | -5% y/y |
| Greater China Revenue · Q1-2026 | $21M | -49% y/y |
| United States Revenue · Q1-2026 | $29M | +31% y/y |
| Cash and Cash Equivalents · 2026-03-31 | $146M | |
| Net Income Attributable to IMAX China · Q1-2026 | $6M | -69% y/y |
Risks flagged
CEO Medical Leave
“Richard Gelfond, the Company's Chief Executive Officer, is on a temporary medical leave of absence.” · word for word
China Revenue Concentration
“Greater China revenue dropped 48.7% YoY to $20.6M, representing 25.3% of total revenue.”
Gross Margin Compression
“Gross margin declined 630 bps YoY to 56.3%.”
24 Apr 2026DEF 14AProxy statement for 2026 Annual General Meeting, disclosing executive compensation, governance, and 2025 performance results.open
Figures in the filing · each found in the filing text
| Global Box Office · FY2025 | $1.28B | +40% y/y |
| Revenue · FY2025 | $410M | +16% y/y |
| Net Income · FY2025 | $46M | +39% y/y |
| Total Adjusted EBITDA · FY2025 | $185M | +33% y/y |
| Adjusted EPS · FY2025 | $1.45 | +53% y/y |
| Total Adjusted EBITDA Margin · FY2025 | 45.1% | |
| System Installations · FY2025 | 160 | |
| System Signings · FY2025 | 166 |
Risks flagged
CEO Medical Leave
“Mr. Gelfond is currently on a temporary medical leave of absence.” · word for word
Key Person Dependency
“The Board appointed Mr. Lister to serve as the Company's interim PEO in addition to his duties as the Company's Chief Legal Officer and Senior Executive Vice President from April 16, 2026 to May 1, 2026, following which Mr. Gelfond will resume the role of PEO.” · word for word
17 Apr 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Key person risk due to CEO medical leave.
“CEO on temporary medical leave; interim PEO appointed.”
30 Mar 20268-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
CEO absence could delay strategic decisions or investor communications
“CEO not participating in public or private events; no timeline for return”
17 Mar 2026SC 13D/AKevin Douglas and related parties sold 568,000 IMAX shares in a block trade, reducing their aggregate stake to 15.5%.open
Figures in the filing · each found in the filing text
| Beneficial ownership percentage (Kevin Douglas) · 2026-03-16 | 15.5% |
Risks flagged
Insider selling pressure
“On March 16, 2026, the Filers sold an aggregate of 568,000 Common Shares in a block sale transaction ... at a price of $37.82 per share.” · word for word
17 Mar 2026SC 13D/AKevin Douglas and related parties sold 568,000 IMAX shares in a block trade, reducing their aggregate stake to 15.5%.open
Figures in the filing · each found in the filing text
| Beneficial ownership percentage (Kevin Douglas) · 2026-03-16 | 15.5% |
Risks flagged
Insider selling pressure
“On March 16, 2026, the Filers sold an aggregate of 568,000 Common Shares in a block sale transaction ... at a price of $37.82 per share.” · word for word
25 Feb 202610-KGlobal Box Office $1.28B (+40% y/y); Domestic Box Office Market Share 5.2; Global Box Office Market Share 3.8open
Figures in the filing · each found in the filing text
| Global Box Office · FY2025 | $1.28B | +40% y/y |
| Domestic Box Office Market Share · FY2025 | 5.2% | |
| Global Box Office Market Share · FY2025 | 3.8% | |
| Total IMAX Systems · 2025-12-31 | 1,864 | +3% y/y |
| New IMAX System Installations · FY2025 | 98 | |
| Backlog of IMAX Systems · 2025-12-31 | 434 | |
| Local Language Box Office · FY2025 | $405M | +66% y/y |
| Number of Films Released · FY2025 | 122 | |
| Number of Local Language Films Released · FY2025 | 67 |
Risks flagged
International Operations Risk
“The Company conducts business internationally, which exposes it to uncertainties and risks that could negatively affect its operations, sales, and future growth prospects.” · word for word
China Concentration Risk
“The Company faces risks in connection with its significant presence in China and the continued expansion of its business there.” · word for word
Backlog Conversion Risk
“The Company may not convert all of its backlog into revenue and cash flows.” · word for word
25 Feb 20268-K · 2.02Revenue $410M (+16% y/y); Net Income $46M (+39% y/y); Cash from Operating Activities $127M (+79% y/y); Guidance: 2026 guidance: $1.4B box office, 160-175 installations, EBITDA margin above 45%earningsopen
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $410M | +16% y/y |
| Net Income · FY2025 | $46M | +39% y/y |
| Cash from Operating Activities · FY2025 | $127M | +79% y/y |
| Global Box Office · FY2025 | $1.28B | |
| Gross Margin · FY2025 | $246M | +29% y/y |
| Adjusted EBITDA · FY2025 | $185M | +33% y/y |
| System Installations · FY2025 | 160 | |
| System Signings · FY2025 | 166 | +28% y/y |
| Local Language Box Office · FY2025 | $405M | +66% y/y |
| Adjusted EBITDA Margin · FY2025 | 45.1% |
Guidance
2026 guidance: $1.4B box office, 160-175 installations, EBITDA margin above 45%
IMAX raised 2026 guidance significantly, expecting record box office, increased installations, and margin expansion, driven by strong content slate and network growth.
Risks flagged
Dependence on blockbuster content slate; any disruption in film production or release schedule could impact box office.
“Guidance relies on strong 2026 slate including Nolan's The Odyssey, Dune: Part Three, etc.”
Currency and geopolitical risks in international markets, especially underpenetrated regions like Japan, Australia, Germany, France.
“Expansion into underpenetrated, high-PSA markets.”
6 Nov 20258-K · 1.01, 2.03, 3.02, 8.01Convertible note coupon rate 0.75open
Figures in the filing · each found in the filing text
| Convertible note coupon rate · 2025-11-06 | 0.8% |
Risks flagged
Potential dilution from conversion of notes.
“Convertible Senior Notes” · word for word
IMAX Corporation — questions
- What did IMAX Corporation file recently?
- 14 SEC filings in the last 12 months. Latest: 8-K on 2026-08-21 — Reported a director or officer change (departure, election, appointment or pay arrangement)
Every figure on this page comes from IMAX Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.